Aims The aim of the present paper was to provide an up‐to‐date view on epidemiology and
risk factors of heart failure (HF) development after myocardial infarction. Methods and results …

Heart failure (HF) complicating myocardial infarction (MI) is common and may be present at
admission or develop during the hospitalization. Among patients with MI, there is a strong …

Aims Patients surviving an acute myocardial infarction (AMI) are at risk of developing
symptomatic heart failure (HF) or premature death. We hypothesized that …

Importance Thyroid hormones play a key role in modulating myocardial contractility.
Subclinical hypothyroidism in patients with acute myocardial infarction is associated with …

Myocardial injury as induced by myocardial infarction results in tissue ischemia, which
critically incepts cardiomyocyte death. Endothelial cells play a crucial role in restoring …

Aims To investigate the association between long-term β-blocker therapy and clinical
outcomes in patients without heart failure (HF) after acute myocardial infarction (AMI) …

Myocardial infarction (MI) is the most common cause of heart failure (HF) worldwide. The
aim of this study was to investigate the role of Klotho in cardiac function and remodeling as …

Diabetes and heart failure (HF) are both global epidemics with tremendous costs on society
with increased rates of HF hospitalizations and worsened prognosis when co-existing …

Heart failure is the prevalent complication of acute myocardial infarction. We aim to identify a
biomarker for heart failure post-acute myocardial infarction. This observational study …

The voltage-dependent anion channel 1 (VDAC1) is a key player in mitochondrial function.
VDAC1 serves as a gatekeeper mediating the fluxes of ions, nucleotides, and other …